In the context of FGF19-dependent tumors, FGF19/FGFR-4 blockade with FGF401 resulted in tumor growth inhibition, reduction of cell proliferation, induction of apoptosis, and improved OS in both orthotopic and ectopic models. The gene discussed is FGF19; the disease is neoplasm.